Études scientifiques :
1 Bukhari S. I., Manzoor M., Dhar M. K. « A comprehensive review of the pharmacological potential of Crocus sativus and its bioactive apocarotenoids ». Biomed Pharmacother [En ligne]. février 2018. Vol. 98, p. 733‑745. Disponible sur : < https://doi.org/10.1016/j.biopha.2017.12.090 >
2 Noorbala A. A. et al. « Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial ». Journal of Ethnopharmacology [En ligne]. 28 février 2005. Vol. 97, n°2, p. 281‑284. Disponible sur : < https://doi.org/10.1016/j.jep.2004.11.004 >
3 Basiri Moghadam M. et al. « Comparison of the Anxiolytic Effects of Saffron (Crocus sativus. L) and Diazepam Before Herniorrhaphy Surgery: A Double Blind Randomized Clinical Trial ». Zahedan Journal of Research in Medical Sciences [En ligne]. 26 mars 2016. Vol. In Press,. Disponible sur : < https://doi.org/10.17795/zjrms-6248 >
*4 Talaei A. et al. « Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial ». Journal of Affective Disorders [En ligne]. 15 mars 2015. Vol. 174, p. 51‑56. Disponible sur : < https://doi.org/10.1016/j.jad.2014.11.035 >
*5 Tabeshpour J. et al. « A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression ». Phytomedicine [En ligne]. 1 décembre 2017. Vol. 36, p. 145‑152. Disponible sur : < https://doi.org/10.1016/j.phymed.2017.10.005 >
*6 Mazidi M. et al. « A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression ». Journal of Complementary and Integrative Medicine [En ligne]. 1 juin 2016. Vol. 13, n°2, p. 195‑199. Disponible sur : < https://doi.org/10.1515/jcim-2015-0043 >